Sciact
  • EN
  • RU

Access to steroidal pyridazines via modified thiohydrazides Full article

Journal RSC Advances
ISSN: 2046-2069
Output data Year: 2016, Volume: 6, Number: 49, Pages: 42863-42868 Pages count : 6 DOI: 10.1039/c6ra06881b
Authors Volkova Y.A. 1 , Antonov Y.S. 1 , Komkov A.V. 1 , Scherbakov A.M. 2 , Shashkov A.S. 1 , Menchikov L.G. 1 , Chernoburova E.I. 1 , Zavarzin I.V. 1
Affiliations
1 N. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, 47 Leninsky prosp., 119991 Moscow, Russia
2 Blokhin N. N. Cancer Research Centre, Ministry of Health of the Russian Federation, 24 Kashirskoe sh., 115478 Moscow, Russia

Abstract: An approach to steroids annulated with pyridazines via cascade imination/electrocyclization of chlorovinyl aldehydes with oxamic acid thiohydrazides is disclosed. A mechanistic rationalization was performed using real-time 1H NMR spectroscopy and computational studies. A series of 18-nor-5α-androsta-2,13-diene[3,2-d]pyridazines, androsta-2-ene[3,2-d]pyridazines and Δ1,3,5(10)-estratrieno[16,17-d]pyridazines were synthesized from native hormones. These compounds were screened for cytotoxicity against the human estrogen-responsive breast cancer cell line MCF-7 and the estrogen-independent breast cancer cell line MDA-MB-231. The structure–activity relationship analysis revealed that the annulation of the pyridazine moiety to the A-ring of the 17β-hydroxy-5α-androsta-2-ene core provides high antiproliferative activity. Compounds 7a and 10b exhibited higher antiproliferative potency than the drug cisplatin. 5α-Androsta-2-ene[3,2-d]pyridazine 10c showed good selectivity against the MCF-7 breast cancer cells.
Cite: Volkova Y.A. , Antonov Y.S. , Komkov A.V. , Scherbakov A.M. , Shashkov A.S. , Menchikov L.G. , Chernoburova E.I. , Zavarzin I.V.
Access to steroidal pyridazines via modified thiohydrazides
RSC Advances. 2016. V.6. N49. P.42863-42868. DOI: 10.1039/c6ra06881b WOS Scopus OpenAlex
Identifiers:
≡ Web of science: WOS:000375611100013
≡ Scopus: 2-s2.0-84969246449
≡ OpenAlex: W2343887259
Altmetrics: